Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Molecules (Basel, Switzerland)|August 28, 2025
Recent Advances in Microtubule Targeting Agents for Cancer TherapyHenrique C Assunção, Patrícia M A Silva, Hassan Bousbaa, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 29, 2024
Time-Lapse Imaging to Analyze Cell Fate in Response to AntimitoticsPatrícia M A Silva, João P N Silva, Bárbara Pinto, et al.
International Journal of Molecular Sciences|January 28, 2026
BCL-2 and BCL-xL in Cancer: Regulation, Function, and Therapeutic TargetingJoão P N Silva, Bárbara Pinto, Patrícia M A Silva, et al.
Biomedicines|December 30, 2025
Galanthamine Fails to Reverse P-gp-Mediated Paclitaxel Resistance in Ovarian Cancer Cell LinesNélia Fonseca, Mariana Nunes, Patrícia M A Silva, et al.
Molecular Pharmaceutics|November 3, 2015
Combinatorial-Designed Epidermal Growth Factor Receptor-Targeted Chitosan Nanoparticles for Encapsulation and Delivery of Lipid-Modified Platinum Derivatives in Wild-Type and Resistant Non-Small-Cell Lung Cancer CellsAna Vanessa Nascimento, Amit Singh, Hassan Bousbaa, et al.
Pharmaceutics|June 28, 2023
Combination Therapy as a Promising Way to Fight Oral CancerJoão P N Silva, Bárbara Pinto, Luís Monteiro, et al.
Molecular Pharmaceutics|September 27, 2014
Mad2 checkpoint gene silencing using epidermal growth factor receptor-targeted chitosan nanoparticles in non-small cell lung cancer modelAna Vanessa Nascimento, Amit Singh, Hassan Bousbaa, et al.
Cancers|June 19, 2024
Coupling Kinesin Spindle Protein and Aurora B Inhibition with Apoptosis Induction Enhances Oral Cancer Cell KillingJoão P N Silva, Bárbara Pinto, Luís Monteiro, et al.
Acta Biomaterialia|October 5, 2016
Overcoming cisplatin resistance in non-small cell lung cancer with Mad2 silencing siRNA delivered systemically using EGFR-targeted chitosan nanoparticlesAna Vanessa Nascimento, Amit Singh, Hassan Bousbaa, et al.
Cancer Letters|October 13, 2018
Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solutionAna C Henriques, Diana Ribeiro, Joel Pedrosa, et al.
Pageof 7